Microsampling & Minimally Invasive Blood Collection Companies Strategic Expansion Initiatives

Top Companies in the Microsampling & Minimally Invasive Blood Collection Market & Their Offerings

The smarter way to monitor the Microsampling & Minimally Invasive Blood Collection Market starts here - Buy Now.

What are the Recent Developments in the Microsampling & Minimally Invasive Blood Collection Market?

• In June 2024, Lindus Health collaborated with Tasso, Inc. to integrate remote blood collection technology into clinical trials, making sample collection more convenient for patients. This partnership supports at-home blood sampling, reduces the burden of site visits, and improves patient comfort and participation in decentralized studies.
• In January 2024, Trajan Scientific and Medical partnered with CliniSciences to expand the distribution of its Neoteryx microsampling solutions, including hemaPEN and Mitra devices, across Europe. This collaboration enhances product access in major European markets and supports the growing adoption of decentralized and patient-focused blood sampling approaches.

Supply Chain Analysis

Clinical Trails

• Clinical trials in microsampling and minimally invasive blood collection are reshaping decentralized research by enabling convenient at-home blood sample collection and improving patient participation. These approaches reduce needle-related discomfort, support remote monitoring, and simplify sample shipment to laboratories, making trials more efficient and patient-centric.
• Key players: Neoteryx (Mitra®), Tasso, Inc.  

Regulatory Approvals

• Regulatory approvals in the microsampling and minimally invasive blood collection market are focused on ensuring device safety, sample accuracy, and user-friendly performance for decentralized and home-based settings. Approvals such as FDA clearance, CE marking, and MHRA compliance are supporting wider adoption.
• Key Takeaways: Becton, Dickinson and Company, Trajan Scientific, Tasso, Your Bio Health continue.

Patient Support and Services

• Patient-centric microsampling and minimally invasive blood collection focus on comfort, convenience, and easy access by enabling blood sample collection from home or remote settings. These simple finger-stick or device-based methods reduce discomfort and anxiety while improving compliance for regular testing and monitoring.
• Key players: Becton, Dickinson and Company, Abbott Laboratories, Trajan Scientific and Medical, Tasso, Inc., YourBio Health, Inc.

Market Growth

The global microsampling & minimally invasive blood collection market size was estimated at USD 2.4 billion in 2025 and is predicted to increase from USD 2.71 billion in 2026 to approximately USD 8 billion by 2035, expanding at a CAGR of 12.8% from 2026 to 2035. The market is growing steadily due to rising demand for patient-friendly diagnostic and home-based sample collection. Increasing use in clinical research, chronic disease monitoring, and advanced low-volume collection technologies is driving continued market expansion.